Covered recipient · General Payments record
HECTOR B SALCEDO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$1,388.06
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $276.23 | 13 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $151.05 | 7 |
| ABBVIE INC. | $66.66 | 3 |
| Amarin Pharma Inc. | $33.73 | 2 |
| Xeris Pharmaceuticals, Inc. | $24.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $16.59 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998781899 | CMS |
| AbbVie Inc. | $26.55 | 07/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998781905 | CMS |
| AbbVie Inc. | $23.52 | 08/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998781911 | CMS |
| Amarin Pharma Inc. | $17.71 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000882265 | CMS |
| Amarin Pharma Inc. | $16.02 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000872429 | CMS |
| Lilly USA, LLC | $27.25 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031692543 | CMS |
| Lilly USA, LLC | $29.70 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031659227 | CMS |
| Lilly USA, LLC | $13.71 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031512489 | CMS |
| Lilly USA, LLC | $22.98 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031659219 | CMS |
| Lilly USA, LLC | $9.63 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031659233 | CMS |
| Lilly USA, LLC | $21.17 | 07/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031573517 | CMS |
| Lilly USA, LLC | $26.61 | 09/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031692537 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.79 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056463585 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.